MCC
VIR icon

Money Concepts Capital’s Vir Biotechnology VIR Stock Holding History

Money Concepts Capital’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-325
Closed -$8.23K – 2820
2022
Q4 		$8.23K Buy
+325
New +$7.97K ﹤0.01% 2106
2022
Q2 		– Sell
-1,726
Closed -$44K – 2584
2022
Q1 		$44K Buy
+1,726
New +$51.2K ﹤0.01% 1293

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Money Concepts Capital's VIR Position: Q1 2023 in Review

Money Concepts Capital sold out of Vir Biotechnology (VIR) in Q1 2023, closing a stake of 325 shares — an estimated $8.23K sold.

Money Concepts Capital first reported a position in VIR in Q1 2022 and held it in 2 quarters. The position peaked at $44K in Q1 2022. 232 funds tracked by Wall St. Rank hold VIR as of Q1 2023.

  • Money Concepts Capital reported no remaining Vir Biotechnology position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 325 Vir Biotechnology shares in Q1 2023, an estimated $8.23K.
  • Money Concepts Capital first reported a position in Vir Biotechnology in Q1 2022 and held it in 2 quarters.
  • Money Concepts Capital's Vir Biotechnology position peaked at $44K in Q1 2022.
  • 232 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.